{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:35:36Z","timestamp":1774038936781,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["40996"],"award-info":[{"award-number":["40996"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anna-Maria Solinas Laroche Allergy and Clinical Immunology Research Fund"},{"DOI":"10.13039\/501100017657","name":"Montreal General Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Evaluating age as a risk factor for susceptibility to infectious diseases, particularly coronavirus disease 2019 (COVID-19), is critical. Cytomegalovirus (CMV) serologic prevalence increases with age and associates with inflammatory-mediated diseases in the elderly. However, little is known regarding the subclinical impact of CMV and risk it poses to healthy older adults. Prior to the COVID-19 pandemic we conducted a study to determine the association of CMV to biologic age and immune dysregulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Community-dwelling, healthy adults older than 60 years were evaluated using DNA methylation assays to define epigenetic age (EpiAge) and T-cell immunophenotyping to assess immune dysregulation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All subjects were healthy and asymptomatic. Those CMV seropositive had more lymphocytes, CD8 T cells, CD28\u2212 T cells, decreased CD4:CD8 cell ratios, and had higher average EpiAge (65.34 years) than those CMV seronegative (59.53 years). Decreased percent CD4 (P\u2005=\u2005.003) and numbers of CD4 T cells (P\u2005=\u2005.0199) correlated with increased EpiAge.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our novel findings distinguish altered immunity in the elderly based on CMV status. Chronic CMV infection in healthy, older adults is associated with indicators of immune dysregulation, both of which correlate to differences in EpiAge.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiab365","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:11:12Z","timestamp":1626117072000},"page":"443-452","source":"Crossref","is-referenced-by-count":31,"title":["Are the Healthy Vulnerable? Cytomegalovirus Seropositivity in Healthy Adults Is Associated With Accelerated Epigenetic Age and Immune Dysregulation"],"prefix":"10.1093","volume":"225","author":[{"given":"Chad","family":"Poloni","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Szyf","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cheishvili","sequence":"additional","affiliation":[{"name":"HKG Epitherapeutics Ltd, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos M","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, Division of Allergy and Clinical Immunology, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Experimental Medicine, The Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"2022020201050945400_CIT0001","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1172\/JCI57834","article-title":"Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies","volume":"121","author":"Sasaki","year":"2011","journal-title":"J Clin Invest"},{"key":"2022020201050945400_CIT0002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bst0310449","article-title":"Effect of age on susceptibility to post-traumatic infection in the elderly","volume":"31","author":"Butcher","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"2022020201050945400_CIT0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/313947","article-title":"Clinical relevance of age-related immune dysfunction","volume":"31","author":"Castle","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2022020201050945400_CIT0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"2022020201050945400_CIT0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2022020201050945400_CIT0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11904-016-0297-9","article-title":"Partners in crime: the role of CMV in immune dysregulation and clinical outcome during HIV infection","volume":"13","author":"Freeman","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2022020201050945400_CIT0007","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jcpa.2009.09.005","article-title":"Senescence of the human immune system","volume":"142","author":"Pawelec","year":"2010","journal-title":"J Comp Pathol"},{"key":"2022020201050945400_CIT0008","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/gerona\/60.5.556","article-title":"An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans","volume":"60","author":"Wikby","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022020201050945400_CIT0009","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/gerona\/glu018","article-title":"CD4:8 ratio &gt;5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study","volume":"70","author":"Adriaensen","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022020201050945400_CIT0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2022020201050945400_CIT0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00430-012-0273-y","article-title":"Viral latency drives \u2018memory inflation\u2019: a unifying hypothesis linking two hallmarks of cytomegalovirus infection","volume":"201","author":"Seckert","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"2022020201050945400_CIT0012","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.79.6.3675-3683.2005","article-title":"Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons","volume":"79","author":"Almanzar","year":"2005","journal-title":"J Virol"},{"key":"2022020201050945400_CIT0013","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/infdis\/jiv277","article-title":"HIV-1 infection accelerates age according to the epigenetic clock","volume":"212","author":"Horvath","year":"2015","journal-title":"J Infect Dis"},{"key":"2022020201050945400_CIT0014","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2022020201050945400_CIT0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/gerona\/glw185","article-title":"Systemic age-associated DNA hypermethylation of ELOVL2 gene: in vivo and in vitro evidences of a cell replication process","volume":"72","author":"Bacalini","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022020201050945400_CIT0016","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"2022020201050945400_CIT0017","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007435-199810000-00006","article-title":"Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects. The SEROCO Study Group","volume":"25","author":"Robain","year":"1998","journal-title":"Sex Transm Dis"},{"key":"2022020201050945400_CIT0018","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","article-title":"Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection","volume":"173","author":"Khan","year":"2004","journal-title":"J Immunol"},{"key":"2022020201050945400_CIT0019","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"2022020201050945400_CIT0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18081742","article-title":"Markers of T cell senescence in humans","volume":"18","author":"Xu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2022020201050945400_CIT0021","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3389\/fmicb.2016.02111","article-title":"Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection","volume":"7","author":"Tu","year":"2016","journal-title":"Front Microbiol"},{"key":"2022020201050945400_CIT0022","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.coi.2012.04.001","article-title":"Properties of end-stage human T cells defined by CD45RA re-expression","volume":"24","author":"Henson","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2022020201050945400_CIT0023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1189\/jlb.0611299","article-title":"The impact of aging on memory T cell phenotype and function in the human bone marrow","volume":"91","author":"Herndler-Brandstetter","year":"2012","journal-title":"J Leukoc Biol"},{"key":"2022020201050945400_CIT0024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0047-6374(84)90152-0","article-title":"Admission criteria for immunogerontological studies in man: the SENIEUR protocol","volume":"28","author":"Ligthart","year":"1984","journal-title":"Mech Ageing Dev"},{"key":"2022020201050945400_CIT0025","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/acel.12005","article-title":"Methylation of ELOVL2 gene as a new epigenetic marker of age","volume":"11","author":"Garagnani","year":"2012","journal-title":"Aging Cell"},{"key":"2022020201050945400_CIT0026","first-page":"753","volume-title":"No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study","author":"Strindhall","year":"2007"},{"key":"2022020201050945400_CIT0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0042-9007.2004.00388.x","article-title":"Continuous cytomegalovirus seroconversion in a large group of healthy blood donors","volume":"86","author":"Hecker","year":"2004","journal-title":"Vox Sang"},{"key":"2022020201050945400_CIT0028","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0531-5565(01)00212-1","article-title":"Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study","volume":"37","author":"Wikby","year":"2002","journal-title":"Exp Gerontol"},{"key":"2022020201050945400_CIT0029","doi-asserted-by":"crossref","first-page":"B378","DOI":"10.1093\/gerona\/50A.6.B378","article-title":"Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors","volume":"50","author":"Ferguson","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022020201050945400_CIT0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4110\/in.2015.15.4.186","article-title":"Cytomegalovirus infection and memory T cell inflation","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw"},{"key":"2022020201050945400_CIT0031","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1590\/S0100-879X2003000600016","article-title":"Lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients","volume":"36","author":"Castro","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"2022020201050945400_CIT0032","doi-asserted-by":"crossref","first-page":"e107167","DOI":"10.1371\/journal.pone.0107167","article-title":"The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons","volume":"9","author":"Willis","year":"2014","journal-title":"PLoS One"},{"key":"2022020201050945400_CIT0033","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/infdis\/jiw371","article-title":"Functional diversity of cytomegalovirus-specific T cells is maintained in older people and significantly associated with protein specificity and response size","volume":"214","author":"Bajwa","year":"2016","journal-title":"J Infect Dis"},{"key":"2022020201050945400_CIT0034","first-page":"227","article-title":"Cytomegalovirus infection accelerates epigenetic aging. Exp Gerontol","volume":"72","author":"Kananen","year":"2015"},{"key":"2022020201050945400_CIT0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19)\u2014United States, February 12-March 16, 2020","volume":"69","author":"CDC COVID-19 Response Team.","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022020201050945400_CIT0036","doi-asserted-by":"crossref","first-page":"e16103","DOI":"10.1371\/journal.pone.0016103","article-title":"Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States","volume":"6","author":"Simanek","year":"2011","journal-title":"PLoS One"},{"key":"2022020201050945400_CIT0037","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/cid\/cit083","article-title":"Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort","volume":"56","author":"Gkrania-Klotsas","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2022020201050945400_CIT0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v9100289","article-title":"Telomere dynamics in immune senescence and exhaustion triggered by chronic viral infection","volume":"9","author":"Bellon","year":"2017","journal-title":"Viruses"},{"key":"2022020201050945400_CIT0039","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/infdis\/jix255","article-title":"Persistent herpesvirus infections and telomere attrition over 3 years in the Whitehall II cohort","volume":"216","author":"Dowd","year":"2017","journal-title":"J Infect Dis"},{"key":"2022020201050945400_CIT0040","doi-asserted-by":"crossref","first-page":"e0117039","DOI":"10.1371\/journal.pone.0117039","article-title":"Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals","volume":"10","author":"Ndumbi","year":"2015","journal-title":"PLoS One"},{"key":"2022020201050945400_CIT0041","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI1101","article-title":"Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients","volume":"101","author":"Spector","year":"1998","journal-title":"J Clin Invest"},{"key":"2022020201050945400_CIT0042","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"2022020201050945400_CIT0043","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab365\/39833820\/jiab365.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/3\/443\/42361149\/jiab365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/3\/443\/42361149\/jiab365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T01:06:33Z","timestamp":1643763993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/3\/443\/6320592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,13]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab365","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,7,13]]}}}